Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Which approach suits a study depends entirely on the research design single-compound vials are also available individually
Standalone GHK-Cu is a single copper peptide
IV glutathione therapy ensures 100% bioavailability, delivering the antioxidant directly into your bloodstream for immediate use by your cells
We monitor you throughout and can adjust speed based on how you're feeling
These strategies have succeeded for small-molecule drugs and a limited number of short peptide fragments
Current AD research focuses on understanding pathology by targeting several mechanisms, such as abnormal tau protein metabolism, -amyloid, inflammatory response, and cholinergic and free radical damage, aiming to develop successful treatments that are capable of stopping or modifying the course of AD (Tamagno et al., 2021)
